bioRxiv Science⌕ Search

Biology subjects

Lundie-Brown, J.

Publications and source records attributed to Lundie-Brown, J..

2 recordsLinked to original sources

Chromatin priming and co-factor availability shape lineage response to the neuronal pioneer factor ASCL1 in pluripotency

Transcription factors act within defined developmental windows, yet how naive pluripotent cells acquire competence to execute specific transcription factor-driven fate programmes remains unclear. Pioneer transcription factors that engage target sites in closed chromatin to initiate gene expression programmes often act at the top of hierarchies in cell identity transitions. However, we show that the ability of ASCL1 to induce a coherent neuronal programme emerges only after exit from pluripotency, coincident with progressive chromatin remodelling and accumulation of permissive histone marks at neuronal ASCL1 target sites. Binding analysis reveals that although ASCL1 can access a subset of neuronal loci in mESCs and EpiLCs, ASCL1 is preferentially diverted to non-neuronal sites, resulting in divergent transcriptional responses. Increasing global histone acetylation enhances activation of individual neuronal genes but is insufficient to drive full neuronal differentiation. In contrast, co-expression of the homeodomain transcription factor PHOX2B redirects ASCL1 towards neuronal targets while suppressing inappropriate programmes in mESCs. These findings demonstrate that ASCL1 pioneer activity is highly context-dependent and that developmental priming of chromatin is essential for appropriate lineage specification. HIGHLIGHTSO_LIEctopic ASCL1 drives non-neuronal transcriptional responses in naive and formative pluripotent cells C_LIO_LIASCL1 occupies distinct, predominantly non-neuronal genomic targets in pluripotent cells due to differential chromatin accessibility C_LIO_LIASCL1 pioneer activity is locus- and cell type-specific and predicted by histone acetylation status C_LIO_LICo-expression of ASCL1 with Phox2 homeodomain cofactors potentiates neuronal lineage acquisition in pluripotent cells C_LI

developmental biology↗

Comparative ASCL1 interactome analysis reveals CDK2-Cyclin A2 as suppressors of differentiation in MYCN-amplified neuroblastoma

Neuroblastoma is a heterogeneous paediatric cancer arising from developmentally arrested neuronal precursors, where restoring differentiation offers therapeutic promise. ASCL1, a pro-neural transcription factor, is widely expressed in neuroblastoma and can drive either proliferation or differentiation depending on the cellular context. Here, we show that distinct MYCN-amplified neuroblastoma cell lines exhibit differing cell cycle and differentiation responses to ASCL1 overexpression. By comparing genome-wide ASCL1 chromatin binding, transcriptional changes, and protein-protein interactions, we found that ASCL1 binds more extensively to neuronal proteins in a cell line that is more susceptible to ASCL1-driven differentiation, but associates with cell cycle regulators in less responsive cells. We show that CDK2-Cyclin A2 bind ASCL1 in less responsive cells, with CDK-mediated phosphorylation of ASCL1 limiting the ability of ASCL1 to drive differentiation. Our study reveals that context-dependent interactions of ASCL1 with protein partners on the chromatin control its ability to re-engage a differentiation program in neuroblastoma.

cancer biology↗